ATHE: alteritytherapeutics.com Market Capitalization

Public company logo of Alterity Therapeutics Ltd (ATHE)

Alterity Therapeutics specializes in discovering therapies for rare brain pathologies. The price action history shown below is based on the 0.04 metric. The business focuses on developing agents to remove excess iron from brain tissues to slow cell death in Parkinson's disease. The primary growth driver will be the upcoming results of Phase II trials for the key drug candidate.

Alterity Therapeutics Ltd. - ATHE Market Value (period 07/04/2022 - 11/14/2026)

ATHE (alteritytherapeutics.com): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Quotes Alterity Therapeutics Limited|ATHE - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Alterity Therapeutics Limited|ATHE - Value Adjusted for Debt and Cash
- issuer book value statistics:
Book Value per Share Alterity Therapeutics|ATHE - Total Stockholders' Equity|Market Value to Book Value Ratio alteritytherapeutics.com|ATHE - Total Business Assets
- debt and solvency information:
Total Debt to Capital Alterity Therapeutics|ATHE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Alterity Therapeutics Limited|ATHE - Company Aggregate Debts|Debt to Book Capitalization Ratio Alterity Therapeutics Limited|ATHE - Company Long-Term Loans and Borrowings|Company Short-Term Debt Alterity Therapeutics|Quick Ratio alteritytherapeutics.com
- financial results and valuation multiples details:
ATHE - Net Profit|Expected Profit Alterity Therapeutics|ATHE - Price to Earnings Ratio|Projected Price to Earnings Alterity Therapeutics Limited|ATHE - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Alterity Therapeutics Limited|ATHE - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Alterity Therapeutics|ATHE - Earnings per share for the trailing year|Quarterly EPS earnings growth alteritytherapeutics.com|ATHE - Expected net earnings per share growth this year|Expected earnings per share growth for next year Alterity Therapeutics
- revenue and sales details:
ATHE - Company Total Sales|Company Future Sales Volume Alterity Therapeutics Limited|ATHE - Price to Sales|Forward Price-to-Revenue Multiple Alterity Therapeutics Limited
Fundamental company analysis:ATHE (Alterity Therapeutics Ltd)
Product sample of Alterity Therapeutics Ltd.

Market capitalization reflects the aggregate value of all shares, measuring current market confidence in the company's assets. The dynamics of this indicator allow for an assessment of business resilience during periods of volatility. By analyzing the market capitalization trend of the company, an investor sees a real-time operational reassessment of risks. For Alterity Therapeutics (ATHE), this metric captures the market reaction to strategic alliances with Parkinson's disease research centers, demonstrating the capitalization of potential in the fight against neurodegeneration.

Key competitors

Biogen - Market Valuation|Market Value NBIX (Neurocrine)|Regencell - Market Capitalization|Market Value AXSM (Axsome Corp)|ACAD: Market Capitalization|Market Value xenon-pharma.com (XENE)|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Market Capitalization|Market Capitalization Prothena Corp|Market Value Alector, Inc. (ALEC)|Market Value ANNX (Annexon Biosciences)|Omeros - Market Valuation|Market Value NGNE (Neurogene Therapeutics)|AC Immune - Market Capitalization|Market Value voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Market Value|Scilex Holding - Market Value|TVGN (Tevogen Bio Holdings, Inc.) - Market Capitalization|Alpha Cognition Corp (ACOG) - Market Capitalization|Market Valuation CGTX (Cognition Therapeutics, Inc.)|Market Value IKT|Cassava Sciences - Market Valuation|Assertio Holdings (ASRT) - Market Value|COYA: Market Valuation|Market Value VTGN (Vistagen Therapeutics)|OVID (ovidrx.com) - Market Valuation|ABOS: Market Value|CRVO (CervoMed) - Market Capitalization|CLNN: Market Value|Market Capitalization PEPG|JUNS - Market Value|Market Value Relmada Therapeutics RLMD|Market Value ANVS|Grace Tx - Market Capitalization|AIFF - Market Capitalization|anewmeds.com (KLTO) - Market Value|Market Valuation NRSN (NeuroSense Therapeutics Ltd.)|RVPH (Reviva Pharmaceuticals) - Market Capitalization|Market Value MetaVia, Inc. MTVA|Market Valuation NRXS (NeurAxis)|Market Capitalization heliusmedical.com (HSDT)|Passage Bio - Market Valuation|Market Value NEUP (Neuphoria Therapeutics, Inc.)|Minerva Neurosciences - Market Capitalization|Market Capitalization athira.com ATHA|ADXN: Market Capitalization|Market Valuation Alzamend Neuro|Market Value Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Market Capitalization|Market Capitalization KTTA|Market Capitalization cortigent.com (CRGT)|Avenue Therapeutics, Inc. - Market Valuation|Market Value BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Market Capitalization|Market Value CHRO (Chromocell)|ELYM: Market Capitalization|Market Value Intra-Cellular Therapies, Inc. (ITCI)|Market Value Longboard Pharmaceuticals, Inc.|Market Capitalization MRNS (Marinus Pharmaceuticals Inc)|Market Capitalization NKGN|NRBO - Market Value|Sage Therapeutics, Inc. - Market Valuation|Market Capitalization synaptogen.com SNPX|TRVN - Market Value|Market Value VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Market Value|Market Value Cerevel Corp (CERE)